{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T05:10:31Z","timestamp":1779426631938,"version":"3.53.1"},"reference-count":10,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Pembrolizumab has become standard of care in early-stage triple-negative breast cancer (TNBC), but its expanding use may induce rare adverse events involving vascular and lymphatic endothelium. Capillary leak syndrome (CLS) remains an exceptionally rare toxicity of PD-1 blockade, scarcely reported in breast cancer, especially in the adjuvant setting. We report the case of a 40-year-old female with early-stage TNBC who presented with progressive dyspnea, diffuse subcutaneous edema and bilateral pleural and peritoneal effusions after two cycles of adjuvant pembrolizumab. Imaging confirmed polyserositis with interstitial pulmonary edema, and laboratory tests showed hypoalbuminemia without other abnormalities. Thoracentesis revealed milky pleural fluid containing chylomicrons, confirming chylothorax. Bronchoalveolar lavage, medical pleuroscopy, and pleural biopsies demonstrated a normal-appearing pleura without malignant or inflammatory infiltrates. Extensive workup ruled out infectious, neoplastic, cardiac, renal, and autoimmune causes, supporting pembrolizumab-induced vascular and lymphatic endothelial dysfunction. Corticosteroid therapy (1 mg\/kg) led to rapid clinical and radiologic resolution. Pembrolizumab was permanently discontinued with no recurrence after corticosteroid tapering. This case highlights a rare but clinically significant immune-related adverse event (irAE) characterized by both vascular and lymphatic capillary leak under pembrolizumab. With PD-1 inhibitors increasingly used in curative TNBC, unexplained serous effusions and edema should prompt consideration of CLS and warrant comprehensive diagnostic evaluation to enable timely immunosuppression.<\/jats:p>","DOI":"10.3389\/fonc.2026.1786343","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T05:00:08Z","timestamp":1779426008000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Pembrolizumab unmasks a capillary leak syndrome with chylothorax in early TNBC"],"prefix":"10.3389","volume":"16","author":[{"given":"Na\u00efla","family":"Benkalfate","sequence":"first","affiliation":[{"name":"Department of Pulmonology, Cayenne University Hospital","place":["French Guiana, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghazi","family":"Hadjamara","sequence":"additional","affiliation":[{"name":"Department of Pathology, Cayenne University Hospital","place":["French Guiana, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Petorin","sequence":"additional","affiliation":[{"name":"Department of Oncology, Cayenne University Hospital","place":["French Guiana, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magaly","family":"Zappa","sequence":"additional","affiliation":[{"name":"Department of Radiology, Cayenne University Hospital","place":["French Guiana, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimable","family":"Habonimana","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, Cayenne University Hospital","place":["French Guiana, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dufens Pierre","family":"Louis","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Cayenne University Hospital","place":["French Guiana, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Laure","family":"Chene","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, Institut du Thorax, Nantes Universit\u00e9, Centre Hospitalo-Universitaire (CHU) Nantes","place":["Nantes, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Patrick","family":"Clarke","sequence":"additional","affiliation":[{"name":"Pulmonology Outpatient Clinic, ELSAN Sant\u00e9 Atlantique Clinic","place":["Saint-Herblain, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renan","family":"Liberge","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging, Nantes Universit\u00e9","place":["CHU Nantes, Nantes, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinane Drak","family":"Alsibai","sequence":"additional","affiliation":[{"name":"Department of Pathology, Cayenne University Hospital","place":["French Guiana, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Defrance","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging, Nantes Universit\u00e9","place":["CHU Nantes, Nantes, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Pistilli","sequence":"additional","affiliation":[{"name":"Gustave Roussy Cancer Center","place":["Villejuif, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baptiste","family":"Boulet","sequence":"additional","affiliation":[{"name":"Gustave Roussy Cancer Center","place":["Villejuif, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soraya","family":"Benguerfi","sequence":"additional","affiliation":[{"name":"Medical Intensive Care Unit, Nantes University Hospital","place":["Nantes, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houari","family":"Aissaoui","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, Cayenne University Hospital","place":["French Guiana, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2409932","article-title":"Overall survival with pembrolizumab in early-stage triple-negative breast cancer","volume":"391","author":"Schmid","year":"2024","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0002-9343(60)90018-8","article-title":"Cyclical edema and shock due to increased capillary permeability","volume":"29","author":"Clarkson","year":"1960","journal-title":"Am J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-153-2-201007200-00005","article-title":"Narrative review: the systemic capillary leak syndrome","volume":"153","author":"Druey","year":"2010","journal-title":"Ann Intern Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1032844","article-title":"Nivolumab-induced capillary leak syndrome associated with chylothorax in a melanoma patient: a case report and review of the literature","volume":"12","author":"Neuville","year":"2022","journal-title":"Front Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13641","article-title":"Immune checkpoint inhibitor\u2013associated capillary leak syndrome: a systematic review and a worldwide pharmacovigilance study","volume":"294","author":"Wong So","year":"2023","journal-title":"J Intern Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocpiqo.2021.01.004","article-title":"Successful treatment of pembrolizumab-induced severe capillary leak syndrome and lymphatic capillary dysfunction","volume":"5","author":"Qin","year":"2021","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.revmed.2022.11.001","article-title":"Immune checkpoint inhibitor\u2013induced systemic capillary leak syndrome: report of two cases","volume":"43","author":"Petitdemange","year":"2022","journal-title":"Rev Med Interne"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2020-0335","article-title":"Nivolumab-induced systemic capillary leak syndrome as an ultra\u2013rare life-threatening phenomenon of late toxicity and intravenous immunoglobulin efficacy","volume":"13","author":"Polishchuk","year":"2021","journal-title":"Immunotherapy"},{"key":"B9","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ejca.2022.11.001","article-title":"Immune-related generalised oedema: a new category of adverse events with immune checkpoint inhibitors","volume":"179","author":"Velev","year":"2023","journal-title":"Eur J Cancer"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.38335","article-title":"Systemic Capillary Leak Syndrome (SCLS) Presentation in Patients Receiving Anti-cancer Treatments","volume":"15","author":"Anipindi","year":"2023","journal-title":"Cureus"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1786343\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T05:00:16Z","timestamp":1779426016000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1786343\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":10,"alternative-id":["10.3389\/fonc.2026.1786343"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1786343","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"article-number":"1786343"}}